7/18/2019 8:32:54 AM
VolitionRx Begins Lung Cancer Clinical Study With Fosun Long March In China
7/10/2019 8:32:21 AM
VolitionRx Secures Additional $1.4 Mln In Non-Dilutive Funding
4/9/2019 8:36:03 AM
VolitionRx Signs MoU With Texas A&M University For Potential Collaboration To Develop Nu.QTM Veterinary Diagnostics
4/3/2019 8:31:23 AM
VolitionRx Limited Extends Clinical Trial Program In Lung Cancer
3/13/2018 4:09:09 PM
VolitionRx Announces Closing Of $8.4 Mln Public Offering Of Common Stock
3/9/2018 9:11:00 AM
VolitionRx Prices $8.4 Mln Public Offering Of Common Stock